Understanding how pharmaceutical distribution works is essential for any manufacturer, importer, or investor planning to enter a new healthcare market. At its core, pharmaceutical distribution is the system that moves a medicine from the factory floor to the patient’s hands — passing through manufacturers, wholesalers, distributors, and finally pharmacies, clinics, or hospitals. In markets like Iraq, where more than 90 percent of medicines are imported and the pharmaceutical sector is worth over USD 3 billion, this system carries extra weight: it determines whether a registered product actually reaches shelves consistently. This guide walks through how pharmaceutical distribution works step by step, who the key players are, and how the process looks specifically inside Iraq.
What Is Pharmaceutical Distribution?
Pharmaceutical distribution marketing refers to the full chain of activities that get a medicine, supplement, or medical device from the manufacturer to the end customer. This includes importation and customs clearance, warehousing under controlled storage conditions, order management, and last-mile delivery to pharmacies, hospitals, and clinics.
Distribution channels in the pharmaceutical industry are not purely logistical, though. A distributor also builds relationships with pharmacists and physicians, manages sales representatives, tracks inventory to avoid stockouts or expiry losses, and reports market feedback back to the manufacturer. Understanding what is pharmaceutical distribution in this fuller sense — logistics plus commercial execution — explains why choosing the right distribution partner often matters more than the product’s registration paperwork alone.
How Does Drug Distribution Work? Step by Step
So, how does drug distribution work in practice? The process generally follows a repeatable sequence, regardless of the country:
1. Manufacturing and quality release — the product is manufactured, tested, and released by the originating factory according to Good Manufacturing Practice standards.
2. Import and regulatory clearance — the product is shipped to the destination market, cleared through customs, and verified against its local registration.
3. Warehousing — the distributor receives the shipment into a licensed warehouse, applying appropriate storage conditions, including cold-chain handling where required.
4. Order aggregation — pharmacies, hospitals, and wholesalers place orders through sales representatives or ordering platforms.
5. Picking, packing, and delivery — the distributor fulfils orders and delivers them through its logistics network, covering both major cities and secondary regions.
6. Sales and promotional support — medical and sales representatives visit pharmacists and physicians to build awareness and drive demand.
7. Reporting and replenishment — sales data feeds back into demand forecasting, so stock levels are adjusted before shortages or overstocking occur.
This is essentially how pharmaceutical distribution works everywhere, but the sequence gets more complex once public-sector tenders, multiple currencies, or fragmented regional markets — as in Iraq — are added into the mix. Companies exploring this process for the first time often benefit from reviewing pharmaceutical distribution channels in Iraq to see how each step maps onto the local market structure.
The Key Players Behind How Pharmaceutical Distribution Works
To fully grasp how pharmaceutical distribution works, it helps to look at who sits inside the chain:
- Manufacturers — responsible for producing the product and holding the regulatory dossier.
- Licensed importers and distributors — the companies that clear customs, warehouse products, and manage the local delivery network.
- Wholesalers and sub-distributors — intermediaries who redistribute stock to smaller pharmacies in secondary cities and provinces.
- Retail pharmacies — the main point of sale for OTC and prescription products in the private sector.
- Hospitals and clinics — direct buyers for hospital-only medicines, medical devices, and aesthetic products.
- Public procurement agencies — in Iraq, this role is held by KIMADIA, which purchases medicines for government hospitals through centralized tenders.
- Sales and medical representatives — the commercial layer promoting products to healthcare professionals.
Pharma distribution channels rarely involve just one of these players in isolation — most products move through several layers before reaching the patient, and each layer adds cost, time, and a point where things can go wrong if the wrong partner is chosen.
How Pharmaceutical Distribution Works in Iraq Specifically
Iraq’s pharmaceutical market is valued at more than USD 3 billion, with distribution and retail activity run mostly by the private sector while public procurement flows through KIMADIA, part of the Ministry of Health. Currency fluctuations and inflation directly affect medicine pricing, and healthcare spending remains around 4 percent of GDP — lower than regional peers — leaving significant room for private-sector distribution networks to grow.
In practice, various channels of distribution in pharmaceutical marketing operate side by side in Iraq: a manufacturer-to-distributor-to-pharmacy route for most private-sector products, a manufacturer-to-hospital route for specialty medicines, and a manufacturer-to-KIMADIA route for public tenders. For a broader look at market fundamentals, see the Iraq pharmaceutical market size and the Iraq healthcare market overview, both of which shape how distributors plan coverage across Baghdad, Basra, Erbil, Sulaymaniyah, and smaller provinces.
Regulatory Steps That Shape How Pharmaceutical Distribution Works
Distribution cannot move faster than regulation allows. Before any product enters the supply chain in Iraq, it typically needs to clear the appropriate registration pathway. This includes the drug registration process in Iraq for pharmaceuticals, medical device registration for diagnostic and clinical equipment, and the supplement registration requirements in Iraq for nutritional and wellness products.
Only once a product is properly registered can a distributor legally import, store, and sell it through pharmacies, hospitals, or tenders. Skipping or rushing this stage is one of the most common reasons international brands experience delays once they try to move into active distribution.
Public vs Private Distribution Pathways in Iraq
Iraq effectively runs two parallel systems. The public pathway flows through KIMADIA’s centralized tenders, favoring manufacturers with competitive pricing, complete registration files, and tender experience. The private pathway is more fragmented, built from licensed importers, wholesalers, and thousands of independent pharmacies spread across the country.
Most international brands start with the private channel, since it offers faster market access, before later pursuing public-sector supply once local registration, pricing references, and distribution history are established. Understanding both pathways — and which one fits a given product category — is a core part of learning how pharmaceutical distribution works in Iraq rather than assuming a single global model applies everywhere.
How to Start a Pharmaceutical Distribution Business
For companies asking how to start a pharma distribution operation, the process generally involves:
- Market research — assessing demand, competition, and pricing for the target product category.
- Licensing — securing an import and wholesale distribution license from the relevant health authority.
- Product registration — completing regulatory submissions for each product to be distributed.
- Warehousing setup — establishing licensed storage, including cold-chain capability if needed.
- Building a sales network — recruiting representatives to cover pharmacies, hospitals, and clinics.
- Establishing supplier relationships — securing distribution rights from manufacturers.
- Setting up reporting systems — tracking sales, inventory, and compliance data.
In a market like Iraq, this process is easier to execute correctly with local guidance, particularly around navigating how to enter the Iraqi pharmaceutical market, where registration timelines, tender rules, and regional logistics differ significantly from other Middle Eastern markets.
Choosing a Distribution Partner in Iraq
Since so much of how pharmaceutical distribution works depends on execution rather than paperwork, the choice of local partner matters enormously. Manufacturers should evaluate:
- Genuine geographic coverage beyond Baghdad
- Experience with the specific product category — OTC, prescription, hospital, or aesthetic
- Cold-chain and warehousing infrastructure
- Regulatory familiarity across drugs, devices, and supplements
- Transparent sales and inventory reporting
A distributor offering structured services across registration, logistics, and commercial execution typically delivers far more consistent results than one focused purely on shipping and storage.
How Lamassu Health Supports Distribution in Iraq
Lamassu Health helps international pharmaceutical, OTC, supplement, and medical aesthetics brands manage the full cycle of how pharmaceutical distribution works inside Iraq — from market assessment and registration support to nationwide logistics, pharmacy and clinic engagement, and ongoing sales reporting.
Rather than treating distribution as a single logistics contract, this integrated approach connects every stage of the chain, helping brands move from a first shipment to a sustainable nationwide presence. Companies planning their entry can review the full set of services, covering everything from tender readiness to commercial launch management.
Conclusion
How pharmaceutical distribution works ultimately comes down to a chain of manufacturers, distributors, wholesalers, pharmacies, and — in Iraq’s case — a public procurement layer through KIMADIA. Each link in that chain adds cost, complexity, and risk, which is why understanding the full process before launch matters as much as the product itself. Companies that map out registration, warehousing, sales coverage, and reporting from day one are far better positioned to build lasting market presence than those that treat distribution as an afterthought once the product is already registered.
Frequently Asked Questions
How does drug distribution work?
Drug distribution follows a chain that starts with manufacturing and regulatory clearance, moves through importation and warehousing, and ends with delivery to pharmacies, hospitals, or clinics through a distributor or wholesaler network. Along the way, sales representatives promote the product, and sales data feeds back into demand forecasting to keep stock levels accurate.
Who are the big 3 pharma distributors?
Globally, the three dominant pharmaceutical distributors are McKesson Corporation, Cencora (formerly AmerisourceBergen), and Cardinal Health, together controlling well over 90 percent of the U.S. distribution market by revenue. In Iraq, the market is far more fragmented, with local and regional private distributors handling most private-sector supply alongside KIMADIA for public procurement.
How to start a pharma distribution?
Starting a pharmaceutical distribution business typically involves securing an import and wholesale license, registering each product with the health authority, setting up licensed warehousing, and building a sales network to reach pharmacies, hospitals, and clinics. In Iraq specifically, this also means understanding KIMADIA’s tender process for public-sector supply alongside the private retail channel.
Who are the big 3 distributors?
In a general healthcare context, this usually refers to the same three companies — McKesson, Cencora, and Cardinal Health — since they rank among the largest distributors in the sector overall, not only in pharmaceuticals. At a country level such as Iraq, no single distributor holds that kind of dominant position; the market instead relies on a wider mix of licensed local and regional players.